AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 8:08:13 PM : Outperform Start Price: $43.41 AZN Score: -12.80

12/13

Featured Broker Partners


Advertisement